As previously reported, Societe Generale analyst Thomas Swoboda downgraded IFF to Hold from Buy with a price target of $80, down from $145, following the company’s “disappointing” Q2 results. The acquisitions of Frutarom in 2018 and DuPont Nutrition & Biosciences in 2021, instead of improving the portfolio and accelerating growth, have resulted in multiple headwinds and hopes that the new management team would deliver a quick turnaround “have not panned out,” says the analyst, who sees “no turnaround in sight.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on IFF:
- IFF falls -17.3%
- IFF falls -19.0%
- IFF falls -18.5%
- IFF price target lowered to $95 from $110 at Credit Suisse
- International Flavors & Fragrances (NYSE:IFF) Plummets On Big Q2 Miss
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue